New research from University College London and Imperial College London elucidates how Polymyxin B, a last-resort antibiotic, kills Gram-negative bacteria by triggering active disruption and shedding of the bacterial outer membrane. Crucially, this lethal effect requires bacterial metabolic activity and energy; dormant cells evade killing. These findings clarify polymyxin’s mode of action and may inform strategies to overcome persistent and resistant infections.